OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy
Bingjie Wang, Qian Wang, Zeyin Liang, et al.
Annals of Hematology (2023) Vol. 102, Iss. 4, pp. 961-966
Open Access | Times Cited: 10
Bingjie Wang, Qian Wang, Zeyin Liang, et al.
Annals of Hematology (2023) Vol. 102, Iss. 4, pp. 961-966
Open Access | Times Cited: 10
Showing 10 citing articles:
Outcomes of Severe Covid-19 Among Patients Who Did and Did Not Receive Tocilizumab: A Two-year Prospective Cohort Study
Branko Beronja, Tatjana Gazibara, Olja Stevanović, et al.
(2025)
Closed Access
Branko Beronja, Tatjana Gazibara, Olja Stevanović, et al.
(2025)
Closed Access
Targeting Inflammation After Hemorrhagic Shock as a Molecular and Experimental Journey to Improve Outcomes: A Review
Kenneth Meza Monge, Astrid Ardon-Lopez, Akshay Pratap, et al.
Cureus (2025)
Open Access
Kenneth Meza Monge, Astrid Ardon-Lopez, Akshay Pratap, et al.
Cureus (2025)
Open Access
Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions
Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei, et al.
Journal of Pharmacology and Pharmacotherapeutics (2025)
Open Access
Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei, et al.
Journal of Pharmacology and Pharmacotherapeutics (2025)
Open Access
Tocilizumab in treating children with refractory septic shock
En‐Pei Lee, Shih‐Hsiang Chen, Han‐Ping Wu
Critical Care (2025) Vol. 29, Iss. 1
Open Access
En‐Pei Lee, Shih‐Hsiang Chen, Han‐Ping Wu
Critical Care (2025) Vol. 29, Iss. 1
Open Access
Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia
Nour Sabiha Naji, Mrudula Sathish, Theodoros Karantanos
Cancers (2024) Vol. 16, Iss. 23, pp. 3974-3974
Open Access | Times Cited: 2
Nour Sabiha Naji, Mrudula Sathish, Theodoros Karantanos
Cancers (2024) Vol. 16, Iss. 23, pp. 3974-3974
Open Access | Times Cited: 2
Natural products for treating cytokine storm–related diseases: Therapeutic effects and mechanisms
Mei Liu, Wang Qing, Wan-Ai Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115555-115555
Open Access | Times Cited: 2
Mei Liu, Wang Qing, Wan-Ai Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115555-115555
Open Access | Times Cited: 2
Outcome of Tocilizumab Treatment in Febrile Neutropenic Children with Severe Sepsis/Septic Shock in a Single-Center Retrospective Case Series
Shih‐Hsiang Chen, Tsung‐Yen Chang, Yi-Lun Wang, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1512-1512
Open Access
Shih‐Hsiang Chen, Tsung‐Yen Chang, Yi-Lun Wang, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1512-1512
Open Access
Efficacy of interleukin-6 inhibitors as a tool for preventive anti-inflammatory therapy for COVID-19
S. К. Zyryanov, О. И. Бутранова, A. A. Abramova
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice (2024), Iss. 1, pp. 4-16
Open Access
S. К. Zyryanov, О. И. Бутранова, A. A. Abramova
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice (2024), Iss. 1, pp. 4-16
Open Access
Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome
Katarina Tomulić Brusich, Kazimir Juričić, Mirna Bobinac, et al.
Annals of Hematology (2023) Vol. 102, Iss. 9, pp. 2633-2634
Closed Access | Times Cited: 1
Katarina Tomulić Brusich, Kazimir Juričić, Mirna Bobinac, et al.
Annals of Hematology (2023) Vol. 102, Iss. 9, pp. 2633-2634
Closed Access | Times Cited: 1
